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Abstracts / Osteoarthritis and Cartilage 22 (2014) S7–S56 S37articular antigen leads to additional pain-related behaviours. This
approach should enable us to dissect relationships between speciﬁc
pain pathways and joint pathology.
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PAIN SIGNALLING IN RODENT JOINTS BY SERINE PROTEASES
J.J. McDougall, A. Reid, F.A. Russell. Dalhousie Univ., Halifax, NS, Canada
Purpose: Serine proteases modulate pain by either activating or dis-
arming protease-activated receptors (PARs). The aim of the present
study was to assess the effect of two serine proteases (cathepsin G and
neutrophil elastase) on knee joint mechanosensitivity and pain in
rodents.
Methods: Electrophysiological recordings from knee joint primary
afferents were carried out in deeply anaesthetised male Wistar rats in
response to normal and hyper-rotation of the knee. Animals were
treated with either normal or denatured cathepsin G (1ng - 10mg; close
intra-arterial injection) and nerve recordings repeated. In separate
experiments, the effect of intra-articular injection of human neutrophil
elastase (1-50mg rat; 1-5mg mouse) on pain behaviour in awake and
unrestrained Wistar rats and c57bl/6 mice was determined by meas-
urement of hindlimb incapacitance (weight bearing) and von Frey hair
tactile allodynia.
Results: Peripheral administration of cathepsin G caused a dose-
dependent reduction in joint mechanosensitivity compared to boiled
enzyme, which had no discernible effect (P<0.05). The desensitizing
effect of cathepsin G occurred with both normal and hyper-rotation of
the knee, with the top dose of the enzyme reducing afferent activity by
around 75%. Intra-articular injection of neutrophil elastase produced a
signiﬁcant (P<0.05) pain behavioural response in both rats and mice
lasting several hours.
Conclusions: Cathepsin G reduced joint mechanosensitivity, probably
by disarming PAR4 (which is pro-nociceptive), or activating PAR1, which
is known to be anti-nociceptive in joints. Local injection of neutrophil
elastase produced a robust pain response in rats and mice, possibly by
activating PAR2. Future studies will determine the distinct PAR path-
ways involved in protease-induced pain regulation in arthritic joints.
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15 YEARS OF THE KOOS: A SYSTEMATIC REVIEW AND META-
ANALYSIS OF MEASUREMENT PROPERTIES
N.J. Collins y, R. Christensen z,x, C.A. Prinsen k, E.M. Bartels z,
C.B. Terwee{, E.M. Roos x. yDept. of Mechanical Engineering, The Univ. of
Melbourne, Melbourne, Australia; z The Parker Inst., Copenhagen Univ.
Hosp., Copenhagen, Denmark; x Inst. of Sports Sci. and Clinical
Biomechanics, Univ. of Southern Denmark, Odense, Denmark; k EMGOþ
Inst. Inst. for Hlth.and Care Res., VU Univ. Med. Ctr., Amsterdam,
Netherlands; {Dept. of Epidemiology and Biostatistics and the EMGOþ
Inst. for Hlth.and Care Res., VU Univ. Med. Ctr., VU Univ. Med. Ctr.,
Amsterdam, Netherlands
Purpose: Patient reported outcomes (PROs) are used across medical
disciplines to follow the course of a disease or evaluate the results of
interventions, with regulatory agencies such as the US Food and Drug
Administration requiring their use in medical product development.
Since its publication in 1998, the ‘Knee Injury and Osteoarthritis Out-
come Score’ (KOOS) has been widely utilised as a PRO in clinical and
research evaluation of knee injuries and osteoarthritis (OA), with more
than 77,000 unique patient datasets available in international registries.
However, no studies to date have summarised the measurement
properties of the KOOS across the available literature, or subjected
individual studies to quality rating. The purpose of this study was to
conduct a systematic review and meta-analysis of KOOS measurement
properties.
Methods: In accordance with PRISMA guidelines, a search strategy
incorporating terms for “KOOS” and “knee” was used to search six
electronic databases with no language restrictions, with the ﬁnal search
conducted on 6th February 2013. Additional papers were identiﬁed
from reference lists and the KOOS website. Two independent reviewers
utilised deﬁned criteria to screen for eligibility: i) primary aim was to
evaluate at least one measurement property of the KOOS or KOOS-PS
(physical function short-form) (e.g. reliability, validity, responsiveness,
interpretability); ii) inclusion of participants of any age suffering from
any knee condition, and/or asymptomatic controls; and iii) KOOS orKOOS-PS were patient-completed. Included studies underwent meth-
odological quality assessment using the COSMIN Checklist by two
independent reviewers. A third reviewer was consulted for discrep-
ancies. Extracted data for test-retest reliability, internal consistency, and
hypothesis testing was pooled where appropriate, using generic inverse
variance (random effects) methodology. Reliability statistics (ICC val-
ues) were analyzed as Fisher-transformation of a correlation coefﬁcient;
having an approximate normal distribution with an estimable standard
error. Inconsistency was assessed via I-squared (I2). This was performed
for all studies (overall), and for subgroup analyses based on participant
age, condition, intervention and language. Qualitative evidence syn-
thesis was performed where data pooling was not possible.
Results: 954 unique records were identiﬁed by the search strategy, with
85 full-text articles assessed for eligibility. 30 studies evaluating 17
different language versions of KOOS, and including more than 5000
participants (mean age range 26 to 77 years), met all eligibility criteria
and were included in subsequent analyses. Studies evaluated partic-
ipants with knee injuries (ACL, meniscus, focal cartilage lesion) or OA,
who underwent no intervention or exercise, weight loss, pharmaco-
logical, and surgical interventions. Pooled estimates for test-retest
reliability from 23 very heterogeneous cohort ﬁndings ranged from 0.84
(sport/recreation subscale [95%CI: 0.78 to 0.88; I2¼87%]) to 0.9 (activ-
ities of daily living [ADL] subscale [0.86 to 0.92; I2¼84%]). Overall, KOOS
subscales demonstrated adequate convergent and divergent construct
validity in comparisonwith the SF-36. KOOS subscales showed stronger
correlations with SF-36 bodily pain (mean r 0.45 to 0.69) and physical
function (0.42 to 0.65) than with role-emotional (0.18 to 0.31) and
mental health (0.04 to 0.33). Responsiveness data was available for 15
unique cohorts, although none followed COSMIN recommendations for
hypothesis testing. KOOS subscales demonstrated largest effect sizes at
3 to 36 months for surgical interventions (ACL reconstruction, cartilage
repair, total knee replacement) (mean effect size pain 1.63; symptoms
0.91; ADL 1.57; sport/recreation 1.19; quality of life 1.78). Only one study
calculated the minimal important change (pain 11.2, symptoms 11.8,
ADL 11.1, sport/recreation 12.1, quality of life 8.7).
Conclusions: Overall, data from meta-analysis revealed that KOOS
demonstrates adequate test-retest reliability for groups (>0.8). As
expected, KOOS is more strongly correlated with physical subscales of
the SF-36 across different conditions, interventions and languages.
While KOOS demonstrates large effect sizes post-surgery, future studies
should prioritise evaluation of longitudinal validity to adhere with
updated recommendations for evaluation of measurement properties.
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ALL-CAUSE MORTALITY AND SERIOUS CARDIOVASCULAR EVENTS IN
PEOPLE WITH HIP AND KNEE OSTEOARTHRITIS: A POPULATION
BASED COHORT STUDY
G.A. Hawker y,z, R. Croxford x, A.S. Bierman y, P.J. Harvey y,z, B. Ravi y,
I. Stanaitis z, L.L. Lipscombe y,z. yUniv. of Toronto, Toronto, ON, Canada;
zWomen’s Coll. Hosp., Toronto, ON, Canada; x Inst. for Clinical Evaluative
Sci. (ICES), Toronto, ON, Canada
Purpose: Osteoarthritis (OA) is under-treated in part due to the high co-
prevalence of other chronic conditions. Approximately 90% of people
aged 65þ years with symptomatic OA have at least one additional
chronic condition; OA and cardiovascular disease, CVD, are among the
most common dyads seen in clinical practice. CVD, in particular, may be
perceived as precluding the use of OA therapies (e.g. NSAIDs). Inad-
equately treated, people with OA may manage their OA by avoiding
activities, like walking, that exacerbate symptoms. Reduced physical
activity may further increase these individuals’ CVD risk. We therefore
examined the contribution of OA disability to other CVD risk factors,
including prior history of a CVD event, on risk for CVD events.
Methods: This retrospective cohort study used data from a population
cohortwith symptomatic hip and kneeOA that was recruited from 1996-
98 through a screening survey of 100% of the population aged 55þ years
in twoOntario regions (n¼2225hadOAconﬁrmedonexamination andx-
ray). The baseline survey assessed: socio-demographics; smoking; self-
reportedheight,weight andNSAIDuse; comorbidity (includingphysician
diagnosis and treatment in thepast year forhighbloodpressure, diabetes,
andheartproblems); andmentalhealth status.OAdisabilitywas assessed
using theWOMAC function subscale, useof awalkingaid (yes/no) and the
Health Assessment Questionnaire walking disability subscale (0–3;
higher scores indicate greater disability). The current study used baseline
surveys linked to provincial health administrative databases.
Abstracts / Osteoarthritis and Cartilage 22 (2014) S7–S56S38Multivariable Cox regression was used to examine the relative con-
tribution of baseline OA disability and pre-existing CVD on time to a
composite CVD outcome (ED visit or hospitalization for AMI, coronary
revascularization, CHF, stroke or TIA, or death) controlling for traditional
CVDrisk factors andother covariates.Wealsoexamined foran interaction
between OA disability and pre-existing CVD. Pre-existing CVD was
deﬁned as the occurrence of 1 hospital discharge for a CVD event in the
5 years prior to baseline assessment. Individuals were censored if they
emigrated, died or at the end of available data (Feb 28, 2012).
Results: 2143 baseline OA participants had complete data and were
included in analyses (mean age 71 yrs; 72% female). At baseline
assessment, 20% had diabetes. 63.5% hypertension, and 40% pre-exist-
ing CVD. 67% were overweight or obese and 51% were prior/current
smokers. Mean WOMAC function score was 41/100 and 73% reported
walking difﬁculty (use of a walking aid or HAQ score>0). Over a median
follow-up of 9.2 yrs (IQR 3.7-15.0 yrs), 1,460 (68%) experienced our
composite CVD outcome. Both pre-existing CVD (p0.05 for all). Con-
trolling for CVD risk factors (age, sex, smoking, BMI, income, hyper-
tension, diabetes, NSAID use and frailty), and specialist visits over the
pre-baseline year, both pre-existing CVD and walking disability
remained signiﬁcant independent predictors of risk for our composite
CVD outcome (adjusted HRs: prior CVD 1.53, 95% CI 1.37-1.70,
p<0.0001; HAQ walking score per unit increase /3 ¼ 1.22, 95% CI 1.15-
1.30, p<0.0001), as shown in Figure 1.
Conclusion: Our ﬁndings indicate that OA-related walking disability is a
potent risk factor for CVD. Controlling for traditional CVD risk factors, the
presence of baselinewalking disability (HAQwalking score 2 versus 0) and
history of a CVD event each increased risk for a subsequent CVD event or
death by approximately 50%. Risk of a CVD event or death at 10 years’ fol-
low-up was 20% higher in those with both risk factors than those with
neither.Figure 1. Multivariate Cox Regression – Relationship between walking
disability, pre-baseline CVD and risk for composite CVD outcome alter
controlling for confounders57
METABOLIC SYNDROME, ACCELERATED AGING AND HAND
OSTEOARTHRITIS: THE HIV METAFIB-OA STUDY
A.-L. Tomi, J. Sellam, K. Lacombe, M. Sebire, C. Rey-Jouvin, A. Miquel,
E. Maheu, P.-M. Girard, J.-L. Meynard, F. Berenbaum. Hosp. Saint Antoine,
Paris, France
Purpose: Obesity is associated with a 2-fold increase of hand osteo-
arthritis (OA). However, the association with MetS or its components,
independently of the weight, has never been investigated in hand OA
(HAO). Since HIV patients are known to have an increased risk of MetS,
we took advantage of a unique cohort of HIV patients w/o MetS to
address whether MetS or its components may increase the risk of HOA.
Method: A case-control study included HIV-infected patients with
MetS (IDF/AHA criteria) and aged 45 - 65. They were paired with HIV-
infected controls without MetS on age, gender, HIV-RNA level and
duration of HIV infection. Hand X-rays were performed and assessed by
two independent readers, after checking for their reproducibility. Hand
OA was deﬁned as a Kellgren-Lawrence score (KL) 2 on 1 joint
(including the thumb). Structural radiographic severity of HOA was
assessed by the sum of KL scores across all joints and by the number ofjoints having KL2 on both hands. Prevalence of HOAwas compared to
the one found in the Framingham study. Logistic and linear regression
models were used to determine risk factors of HOA.
Results: 301 patients (88% male, mean age (SD): 53.4 (5.0) years, mean
estimated duration of HIV-infection18 (7) years, mean body mass index
(BMI): 24.9 (5.8)) were included, of whom 152 were cases (BMI (SD):
26.4 (4.8)] and 149 (BMI (SD): 23.5 (6.5)) were controls. Overall HOA
prevalence was 55.6% and was higher in MetSþ (64.7%) than MetS-
patients (46.3%, p¼0.002). Thumb base OA (i.e., rhizarthrosis (RZ)) was
also more frequently observed in MetSþ patients (26.1 vs 14.1%,
p¼0.01). Concerning the severity of HOA, mean (SD) sum of KL score
was higher in MetSþ (6.8, 0.9) than MetS- patients (3.7, 0.5), p¼0.002.
The number of affected joints was higher in [MetSþ (3.2, 0.4) than
MetS- patients (1.8, 0.2); p¼0.002. Inmultivariate analysis, the presence
ofMetS independently increased the risk of HOA (OR¼2.23, 95%CI: 1.26-
3.96; p¼0.002) as well as age (OR¼1.18, 95%CI: 1.12-1.25; p¼0.00001)
age. A similar tendency was also observed for RZ (MetS: OR¼1.86, 95%
CI: 0.98-3.45; age: OR¼1.08, 95%CI: 1.02-1.25). MetS was associated
with more severe HOA: in multivariate analysis, it was independently
correlated with the sum of KL scores (b¼2.1; p¼0.04) as well as with the
number of affected joints (b¼1.02; p¼0.04). Age was also associated
with these 2 features of radiographic severity (KL scores sum: b¼0.43,
p¼0.0001; number of affected joints: b¼0.21; p¼0.0001). Considering
each metabolic component separately, insulinoresistance assessed by
HOMA-IR tended to be associated with HOA (p¼0.06) in the univariate
(but not multivariate) analysis and was correlated with the number of
affected joints (p¼0.05). No association between BMI, dyslipidemia and
HOA was observed. Finally and as expected, prevalence of HOA was
higher in the HIV-infected population than in the general population in
the same age group (56% for men in the present study vs. 38% in the
Framingham study). No association was identiﬁed between HOA and
previous/current exposure to protease inhibitors or HIV characteristics
(viral load, CD4 count at inclusion and nadir, T4/T8 rate, duration of HIV
infection).
Conclusion: Such a study emphasizes for the 1st time the link between
HIV infection and OA, through the accelerated aging and MetS. Thanks
to this unique cohort worldwide, we show for the ﬁrst time an associ-
ation of HOA with MetS independently of obesity (i.e. BMI). This study
opens a new ﬁeld of experimental research in order to understand the
relationships between OA and metabolic disorders beyond the scope of
obesity.
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INFLAMMATORY ULTRASOUND FEATURES SHOW STRONG AND
INDEPENDENT ASSOCIATIONS WITH PROGRESSION OF
STRUCTURAL DAMAGE AFTER 2.5 YEARS OF FOLLOW-UP IN HAND
OSTEOARTHRITIS PATIENTS
M.C. Kortekaas, W.-Y. Kwok, M. Reijnierse, M. Kloppenburg. Leiden Univ.
Med. Ctr., Leiden, Netherlands
Purpose: Several cross-sectional studies in hand osteoarthritis (OA)
have shown that inﬂammatory ultrasound (US) features are frequently
present in hand joints and are associated with pain. The objective of the
present longitudinal study was to investigate the course of inﬂamma-
tory US features and their relation to structural damage over 2.5 years of
follow-up.
Methods: 56 consecutive hand OA patients (mean age 61.2 years, 85.7%
female), fulﬁlling the ACR classiﬁcation criteria, were included in the
study. At baseline and after 2.5 years follow-up standardized ques-
tionnaires, radiographs and US were performed. Using US synovial
thickening, effusion and power Doppler signal (PDS) were assessed on a
0-3 scale in all DIP, PIP, 1st CMC, MCP and 1st IP joints following a
validated method. Baseline and follow-up radiographs were scored for
osteophytes and joint space narrowing (JSN) in all hand joints following
the OARSI atlas to assess progression. Progression was deﬁned as one
grade increase of either osteophytes or JSN at follow-up. With gener-
alized estimated equations relative risks were calculated and presented
as odds ratios (ORs) with 95% conﬁdence intervals (CI) for the associ-
ations between inﬂammatory US features and radiographic progression
in separate hand joints. Adjustments were made for patient effect, age,
gender, BMI, baseline osteophytes and JSN scores, and other inﬂam-
matory US features.
Results: Of 1680 joints 8.4%, 8.7%, and 19.8% had synovial thickening,
effusion or PDS at baseline, respectively. 120 and 96 joints showed
progression of osteophytes and JSN, respectively. Independent
